CATHI Joins with VSS to Launch World’s First Online Training Program for Endovascular Simulation

CATHI (Germany-based leading endovascular simulator supplier ) has joined forces with UK-based Vascular Simulation Solutions (VSS) to offer the world’s first on-line training masterclass using endovascular simulation coupled to a structured curriculum.

At its heart is the state-of-the-art CATHIS® simulator, which is fully functional with all standard software systems including every iOS system and Oculus VR (virtual reality).

The training is supported by a structured curriculum, delivered by specialist endovascular instructors with many years‘ clinical experience. The Program is targeted at specialist trainees in every year of their course, medical students (condensed course), and interested interventionists. The scope of the package includes EVAR for aneurysm repair, carotid, renal, iliac, femoral and tibial artery angioplasties. In addition, the curriculum includes training on emergency vascular cases such as ruptured aneurysms and visceral bleeding and trauma.

“The importance of periodical continuous education, training and structured curricula of interventional procedures has been confirmed by numerous clinical experts around the globe“, said CATHI Managing Director Marketing & Sales Manuela Werner. “With this joint venture between VSS and our company we are combining top level expertise with our near to reality simulation systems. We are very pleased to be cooperating with the very experienced vascular and endovascular surgeon Dr. Abdullah Jibawi.“

“We have built our curriculum with the end user in mind in every minute detail. We want to answer the real need for training by allowing a layer by layer build up of skills and decision making, associated with availability of performing procedure where and when the trainees feel so“, added Consultant Vascular Surgeon Dr Abdullah Jibawi. “Our program introduces the ability to train interventionists over a specified period of time, followed by a customised exposure to a specified product line to fine tune their experience as needed and required.“

The program is accredited by the Royal College of Surgeons of Edinburgh for Continuing professional development (CPD), valued at 12 CPD points.

SourceCATHI
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version